BAXTER INTERNATIONAL INC false 0000010456 0000010456 2020-03-17 2020-03-17 0000010456 us-gaap:CommonStockMember 2020-03-17 2020-03-17 0000010456 bax:M0Member 2020-03-17 2020-03-17 0000010456 bax:OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember 2020-03-17 2020-03-17 0000010456 bax:OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember 2020-03-17 2020-03-17 0000010456 bax:ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember 2020-03-17 2020-03-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 17, 2020

Baxter International Inc.

 

(Exact name of registrant as specified in its charter)

Delaware

 

(State or other jurisdiction of incorporation)

1-4448

 

36-0781620

(Commission File Number)

 

(I.R.S. Employer Identification No.)

One Baxter Parkway, Deerfield, Illinois

 

60015

(Address of principal executive offices)

 

(Zip Code)

(224) 948-2000

 

(Registrant’s telephone number, including area code)

                    

 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $1.00 par value

 

BAX (NYSE)

 

New York Stock Exchange

 

 

Chicago Stock Exchange

1.3% Global Notes due 2025

 

BAX 25

 

New York Stock Exchange

1.3% Global Notes due 2029

 

BAX 29

 

New York Stock Exchange

0.4% Global Notes due 2024

 

BAX 24

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

  Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act:  


Item 2.02 Results of Operations and Financial Condition.

On March 17, 2020, Baxter International Inc. (the Company) issued an earnings press release for the period ended December 31, 2019. The press release, including attachments, is furnished as Exhibit 99.1 to this report.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits.

Exhibit Number

   

Description

         
 

99.1

   

Press Release Dated March 17, 2020.

         
 

104

   

Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 17, 2020

BAXTER INTERNATIONAL INC.

     

By:

 

/s/ James K. Saccaro

Name:

 

James K. Saccaro

Title:

 

Executive Vice President and

Chief Financial Officer